Targeted Osmotic Lysis (TOL) is investigational. It has not been approved by the FDA for any indication. It is not available as a treatment. Content on this page is educational and describes published scientific literature. It does not describe an available treatment, it does not report results in patients, and it does not offer access to any therapy.

Three Decades · Operating Record · Dallas

Career timeline.

Operating record across three decades in FDA-regulated healthcare. Verified company-by-company, year by year.

Three decades in motion.